Lunchtime media briefings in the ACG Press Room, Chesapeake G-H, are planned on the following topics:
Monday, October 31, 2010, 1:15 pm EDT
"Hepatitis C: Improving Sustained Viral Response & Screening Strategies for a Silent Epidemic"
Highlighting research on the effectiveness of new treatment options, particularly among African Americans and patients who have previously failed therapy for Hepatitis C, as well as screening strategies for patients based on age and risk factors during routine GI visits.
Paul Y. Kwo, M.D., FACG, Indiana University Department of Medicine, Indianapolis, IN
Mitchell L. Shiffman, M.D., FACG, Liver Institute of Virginia, Bon Secours Health System, Newport News, VA
F. Fred Poordad, MD, Center for Disease and Transplantation, Cedars-Sinai, Los Angeles, CA
Moderator: Dawn Torres, MD, MAJ MC, Walter Reed National Military Medical Center
Media may access Hepatits C Press Briefing remotely on Monday:
Toll-free Dial-in: 1-888-850-4523
Participant code: 424049
Tuesday, October 19, 2009, 12:45 pm CDT
"Good, Bad and Ugly Bugs: Mother Nature as a Treatment for Better Health in the GI Tract"
Highlighting new clinical science that explores the role of the "gut microbiota" -- the bacterial composition of the GI tract -- and the efficacy of probiotics in treating various GI conditions, including antibiotic-associated diarrhea, abdominal discomfort and bloating. The press briefing will also feature recent studies, including a long-term follow-up study, evaluating the effectiveness of fecal microbiota transplant for recurrent C. difficile infection and for the potential treatment of Inflammatory Bowel Disease.
Mark H. Mellow, M.D., FACG, Integris Digestive Health Center, Oklahoma City, OK
Fergus Shanahan, M.D., BSc., National University of Ireland at Cork
|Contact: Jacqueline Gaulin|
American College of Gastroenterology